Cargando…
Anti-IL-10 antibody in systemic lupus erythematosus
PURPOSE: IL-10 is a cytokine known to inhibit inflammatory cytokines. To determine its role in the pathogenesis of systemic lupus erythematosus (SLE), the presence of anti-IL-10 antibody is required to be examined. Although antibodies against cytokines are known to be present in SLE, no studies have...
Autores principales: | Uchida, Marina, Ooka, Seido, Goto, Yutaka, Suzuki, Kanako, Fujimoto, Hisae, Ishimori, Kana, Matsushita, Hiromi, Takakuwa, Yukiko, Kawahata, Kimito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440452/ https://www.ncbi.nlm.nih.gov/pubmed/30988645 http://dx.doi.org/10.2147/OARRR.S191953 |
Ejemplares similares
-
Hydroxychloroquine Improves the Disease Activity and Allows the Reduction of the Corticosteroid Dose Regardless of Background Treatment in Japanese Patients with Systemic Lupus Erythematosus
por: Hanaoka, Hironari, et al.
Publicado: (2019) -
Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV
por: Hanaoka, Hironari, et al.
Publicado: (2018) -
Usefulness of (123)I-BMIPP and (201)TlCl nuclide scintigraphy in evaluation of myocarditis in patients with polymyositis or dermatomyositis
por: Okada, Yukinori, et al.
Publicado: (2021) -
Discoid Lupus Erythematosus Complicated with Pregnancy-induced Hemophagocytic Syndrome
por: Takada, Hideto, et al.
Publicado: (2017) -
Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome
por: Hanaoka, Hironari, et al.
Publicado: (2018)